GMP compliance Saudi Arabia

GCC 2026 Regulatory Trends Shaping Pharma and Biotech

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

GCC pharma regulations in 2026 emphasize eCTD v4.0 adoption, harmonization, real-world evidence, and strict Saudi/UAE rules. Strategic compliance and local QPPV roles are key for market access.

GCC 2026 Regulatory Trends Shaping Pharma and Biotech Read More »

Biotech in the GCC: Top Regulatory Challenges and Proven Solutions

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

GCC biotech firms face complex regulatory challenges in Saudi SFDA and UAE MOHAP approvals. PharmaOasis Germans EG offers proven solutions like eCTD submissions, GMP compliance, QPPV, and Arabic labeling support.

Biotech in the GCC: Top Regulatory Challenges and Proven Solutions Read More »